KIDS
Income statement / Annual
Last year (2024), OrthoPediatrics Corp.'s total revenue was $204.73 M,
an increase of 37.65% from the previous year.
In 2024, OrthoPediatrics Corp.'s net income was -$37.82 M.
See OrthoPediatrics Corp.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$204.73 M |
$148.73 M |
$122.29 M |
$98.05 M |
$71.08 M |
$72.55 M |
$57.56 M |
$45.62 M |
$37.30 M |
$31.00 M |
| Cost of Revenue |
$56.13 M
|
$37.48 M
|
$31.63 M
|
$24.65 M
|
$16.05 M
|
$17.93 M
|
$14.88 M
|
$11.17 M
|
$10.93 M
|
$9.37 M
|
| Gross Profit |
$148.60 M
|
$111.25 M
|
$90.66 M
|
$73.40 M
|
$55.03 M
|
$54.62 M
|
$42.68 M
|
$34.45 M
|
$26.37 M
|
$21.64 M
|
| Gross Profit Ratio |
0.73
|
0.75
|
0.74
|
0.75
|
0.77
|
0.75
|
0.74
|
0.76
|
0.71
|
0.7
|
| Research and Development Expenses |
$11.03 M
|
$10.20 M
|
$8.01 M
|
$5.54 M
|
$5.27 M
|
$5.75 M
|
$4.73 M
|
$3.42 M
|
$2.22 M
|
$1.79 M
|
| General & Administrative Expenses |
$102.79 M
|
$75.42 M
|
$59.38 M
|
$46.06 M
|
$38.32 M
|
$26.66 M
|
$20.94 M
|
$16.97 M
|
$13.61 M
|
$11.41 M
|
| Selling & Marketing Expenses |
$64.30 M
|
$51.40 M
|
$45.05 M
|
$39.67 M
|
$31.85 M
|
$31.28 M
|
$26.56 M
|
$20.53 M
|
$16.66 M
|
$15.03 M
|
| Selling, General & Administrative Expenses |
$167.09 M
|
$126.82 M
|
$104.44 M
|
$85.73 M
|
$70.17 M
|
$57.95 M
|
$47.50 M
|
$37.50 M
|
$30.27 M
|
$26.44 M
|
| Other Expenses |
$0.00
|
$0.00
|
-$1.80 M
|
$1.08 M
|
$20,000.00
|
-$70,000.00
|
-$217,000.00
|
$30,000.00
|
$1.03 M
|
-$31,000.00
|
| Operating Expenses |
$178.12 M
|
$137.02 M
|
$112.45 M
|
$91.28 M
|
$75.44 M
|
$63.70 M
|
$52.23 M
|
$40.92 M
|
$32.49 M
|
$28.23 M
|
| Cost And Expenses |
$234.25 M
|
$174.50 M
|
$144.08 M
|
$115.92 M
|
$91.49 M
|
$81.63 M
|
$67.11 M
|
$52.09 M
|
$43.43 M
|
$37.60 M
|
| Interest Income |
$0.00
|
$198,000.00
|
$2.42 M
|
$2.25 M
|
$3.41 M
|
$3.54 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.62 M
|
$0.00
|
$2.42 M
|
$2.25 M
|
$3.41 M
|
$3.54 M
|
$2.26 M
|
$2.49 M
|
$1.48 M
|
$1.23 M
|
| Depreciation & Amortization |
$19.08 M
|
$17.39 M
|
$13.10 M
|
$10.68 M
|
$7.91 M
|
$4.64 M
|
$2.89 M
|
$2.41 M
|
$1.90 M
|
$1.85 M
|
| EBITDA |
-$10.44 M |
-$8.38 M |
-$7.93 M |
-$7.19 M |
-$22.35 M |
-$4.51 M |
-$6.88 M |
-$4.04 M |
-$3.19 M |
-$4.77 M |
| EBITDA Ratio |
-0.05
|
-0.06
|
-0.09
|
-0.06
|
-0.17
|
-0.06
|
-0.12
|
-0.09
|
-0.09
|
-0.15
|
| Operating Income Ratio |
-0.14
|
-0.17
|
-0.18
|
-0.18
|
-0.29
|
-0.13
|
-0.17
|
-0.14
|
-0.16
|
-0.21
|
| Total Other Income/Expenses Net |
-$12.41 M
|
$4.45 M
|
$18.10 M
|
$486,000.00
|
-$6.91 M
|
-$3.61 M
|
-$2.47 M
|
-$2.46 M
|
-$445,000.00
|
-$1.26 M
|
| Income Before Tax |
-$41.93 M
|
-$21.31 M
|
-$3.69 M
|
-$17.39 M
|
-$33.67 M
|
-$12.69 M
|
-$12.03 M
|
-$8.93 M
|
-$6.57 M
|
-$7.85 M
|
| Income Before Tax Ratio |
-0.2
|
-0.14
|
-0.03
|
-0.18
|
-0.47
|
-0.17
|
-0.21
|
-0.2
|
-0.18
|
-0.25
|
| Income Tax Expense |
-$4.11 M
|
-$338,000.00
|
-$4.95 M
|
-$1.13 M
|
-$723,000.00
|
$4.51 M
|
-$217,000.00
|
$2.52 M
|
$2.51 M
|
$1.24 M
|
| Net Income |
-$37.82 M
|
-$20.97 M
|
$1.26 M
|
-$16.26 M
|
-$32.94 M
|
-$17.20 M
|
-$12.03 M
|
-$8.93 M
|
-$6.57 M
|
-$7.89 M
|
| Net Income Ratio |
-0.18
|
-0.14
|
0.01
|
-0.17
|
-0.46
|
-0.24
|
-0.21
|
-0.2
|
-0.18
|
-0.25
|
| EPS |
-1.64 |
-0.92 |
0.0596 |
-0.84 |
-1.82 |
-1.18 |
-0.96 |
-1.85 |
-0.87 |
-1.05 |
| EPS Diluted |
-1.64 |
-0.92 |
0.059 |
-0.84 |
-1.82 |
-1.18 |
-0.96 |
-1.85 |
-0.87 |
-1.05 |
| Weighted Average Shares Out |
$23.08 M
|
$22.68 M
|
$20.70 M
|
$19.27 M
|
$18.06 M
|
$14.62 M
|
$12.57 M
|
$4.82 M
|
$7.51 M
|
$7.51 M
|
| Weighted Average Shares Out Diluted |
$23.08 M
|
$22.68 M
|
$20.95 M
|
$19.27 M
|
$18.06 M
|
$14.62 M
|
$12.57 M
|
$4.82 M
|
$7.51 M
|
$7.51 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
